Controversies with Kalydeco: Newspaper coverage in Canada and the United States of the cystic fibrosis “wonder drug” Christen Rachul, Maeghan Toews, Timothy Caulfield Journal of Cystic Fibrosis Volume 15, Issue 5, Pages 624-629 (September 2016) DOI: 10.1016/j.jcf.2016.03.006 Copyright © 2016 The Authors Terms and Conditions
Fig. 1 Framing of news articles by country. Journal of Cystic Fibrosis 2016 15, 624-629DOI: (10.1016/j.jcf.2016.03.006) Copyright © 2016 The Authors Terms and Conditions
Fig. 2 Attribution of cost of Kalydeco to different actors. Journal of Cystic Fibrosis 2016 15, 624-629DOI: (10.1016/j.jcf.2016.03.006) Copyright © 2016 The Authors Terms and Conditions
Fig. 3 Responsibility to address funding concerns. Journal of Cystic Fibrosis 2016 15, 624-629DOI: (10.1016/j.jcf.2016.03.006) Copyright © 2016 The Authors Terms and Conditions